| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.91B | +8.3% |
| Cost of Revenue | $1.34B | +9.0% |
| Gross Profit | $569.5M | +6.6% |
| R&D Expense | $148.0M | +3.9% |
| SG&A Expense | $102.2M | +5.0% |
| Operating Income | $44.1M | +70.0% |
| Pre-tax Income | $32.8M | +135.1% |
| Net Income | $42.3M | +1224.6% |
| EPS (Basic) | $0.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.9M | -46.7% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $360.2M | -2.7% |
| Current Assets | $558.0M | -14.9% |
| Total Assets | $1.61B | -6.3% |
| Current Liabilities | $521.0M | +7.3% |
| Stockholders' Equity | $907.2M | -13.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $208.4M | +13.0% |
| Capital Expenditures | $44.9M | +27.8% |
| Investing Cash Flow | -$40.9M | -36.0% |
| Financing Cash Flow | -$277.3M | -177.4% |
| Free Cash Flow | $163.4M | +9.6% |
| +1500.0% |
| EPS (Diluted) | $0.13 | +1400.0% |